Skip to main content

About
Research and Development
- CPI-613^® (devimistat)
- Pipeline
Leadership
Clinical Trial Enrollment
Contact Us

News & Investors
Scientific Exchange
- Publications
- Conference Presentations
Work With Us
Compassionate Use

Clinical Trial Enrollment Contact Us

Investor/Media Kit

News & Investors

Press Releases
News Coverage
Investor/Media Kit
Request Information

Investor/Media Kit Materials

Executive Management Bios
Cornerstone Pharma CPI-613 FactSheet

(609) 409-7050
info@cornerstonepharma.com

Cornerstone Pharmaceuticals, Inc. 1 Duncan Drive
Cranbury, NJ 08512

Quick Links

Home
Press Releases
About
Partnering
Research and Development
Careers
Leadership
Patient Resources

Stay in Touch

LinkedIn
Facebook
Twitter

© 2022 Cornerstone Pharmaceuticals, Inc. All Rights Reserved

Terms of Service
Privacy Policy
Terms of Use